| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441142 | European Journal of Cancer | 2016 | 8 Pages |
Abstract
Our study confirmed that IL-10 is a useful biomarker for the diagnosis of PCNSL. We highlight new findings showing that the IL-10 level in the CSF could be used as a surrogate marker for CSF involvement and that the post-treatment IL-10 concentration could complement standard MRI for therapeutic response assessment in PCNSL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ludovic Nguyen-Them, Myrto Costopoulos, Marie-Laure Tanguy, Caroline Houillier, Sylvain Choquet, Hind Benanni, Rwaida Elias-Shamieh, Marine Armand, Geraldine Faivre, Sylvie Glaisner, Sandra Malak, Jacques Vargaftig, Khê Hoang-Xuan, Guido Ahle,